We are live on ! Find out more
APUS

Apimeds Pharmaceuticals US
APUS

6 hedge funds and large institutions have $803K invested in Apimeds Pharmaceuticals US in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $649K → $803K (+$154K)

3.25% more ownership

Funds ownership: 0.31% → 3.57% (+3.3%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

14% less funds holding

Funds holding: 7 → 6 (-1)

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HTHT
Hemenway Trust Hemenway Trust
New Hampshire
+$3.71M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$550K
3
TSS
Two Sigma Securities
New York
+$159K
4
UBS Group
UBS Group
Switzerland
+$62.2K

Top Sellers

1
Jane Street
Jane Street
New York
-$44.6K
2
Bank of America
Bank of America
North Carolina
-$66
3
TRCT
Tower Research Capital (TRC)
New York
-$16
Name Holding Trade Value Shares
Change 		Change in
Stake
HTHT
1
Hemenway Trust Hemenway Trust
New Hampshire
$490K +$3.71M +246,600 +900%
VCM
2
Vanguard Capital Management
Pennsylvania
$172K +$1.44M +95,929 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$71.7K +$550K +36,562 +1,048%
VFT
4
Vanguard Fiduciary Trust
Pennsylvania
$43K +$362K +24,039 New
TSS
5
Two Sigma Securities
New York
$18.9K +$159K +10,550 New
UBS Group
6
UBS Group
Switzerland
$7.49K +$62.2K +4,129 +7,119%
Jane Street
7
Jane Street
New York
– -$44.6K -2,719 Closed
Bank of America
8
Bank of America
North Carolina
– -$66 -4 Closed
TRCT
9
Tower Research Capital (TRC)
New York
– -$16 -1 Closed